Bayer Seeks Australian Approval for VIMOY iblon Fungicide

Bayer has applied to register its new fungicide VIMOY iblon in Australia after three years of comparative field trials.

Updated on Nov. 11, 2026 in Botany

Bayer Seeks Australian Approval for VIMOY iblon Fungicide

Bayer has submitted an application to register the fungicide VIMOY iblon in Australia. Trials conducted over three years across the country found it consistently provided better control of key cereal diseases than the benchmark product Aviator Xpro.

Why it matters

Disease resistance has become more prevalent over the last decade, making alternative fungicide options and resistance-management tools increasingly relevant to Australian growers. VIMOY iblon is designed for use in tank mixtures with prothioconazole to support that goal.

The evidence comes from three years of comparative field trials against Aviator Xpro, with VIMOY iblon applicable up to wheat growth stage Z62 and barley up to Z45, subject to regulatory approval. Final APVMA decisions on the registrations and the additional crops and diseases remain unresolved.

The players

Bayer

Bayer is a multinational life sciences company with a large crop science division that develops and markets crop protection products, including fungicides, across global agricultural markets.

Australian Pesticides and Veterinary Medicines Authority (APVMA)

The APVMA is the Australian federal regulator responsible for assessing and registering agricultural and veterinary chemical products before they can be sold and used in Australia.

The details

VIMOY iblon is a single-active Succinate Dehydrogenase Inhibitor fungicide that sits alone in a subgroup of Group 7 fungicides, developed by Bayer with the active ingredient isoflucypram. It uses Bayer's Leafshield formulation technology and does not require an adjuvant.

Timeline

  1. Over the past three years: comparative field trials against Aviator Xpro were conducted across the country.

  2. Over the last decade: disease resistance became more prevalent.

  3. 2027 cropping season: anticipated registration of VIMOY iblon, subject to APVMA approval.

The Big Picture

VIMOY iblon is positioned as a successor to the benchmark Aviator Xpro, offering broader application timing and stronger control across key cereal diseases. Its tank-mix use with prothioconazole reflects a wider industry push to manage fungicide resistance in Australian cereal crops.

If approved, VIMOY iblon could give Australian cereal growers another option for managing key diseases and resistance, with application possible later in the wheat crop cycle than Aviator Xpro. Growers should watch for APVMA decisions before planning use in the 2027 season.

The takeaway

Fungicide resistance is becoming harder to manage, so tools that pair well with existing products and offer flexible timing could matter for growers. Keep an eye on APVMA registration decisions before making plans around VIMOY iblon.

What happens next

Registration of VIMOY iblon is anticipated for the 2027 cropping season, subject to APVMA approval.

Further reading

For more on plant disease and crop science, explore our Botany section.

Source note: This article includes information reported by Grain Central.